Abbott | ABT - Créances Commerciales





Créances Commerciales Changement Date
Abbott USD 11.22B 655M 2026-03
Agilent USD 1.5B 23M 2026-03
AtriCure USD 71.31M 4.66M 2026-03
Baxter International USD 1.7B 310M 2026-03
Becton, Dickinson and Co. USD 2.2B 303M 2026-03
Bio-Rad Laboratories USD 460.6M 4.1M 2025-12
Boston Scientific USD 2.93B 98M 2025-12
Cooper Companies USD 809.2M 2.1M 2026-03
Danaher USD 4.96B 205M 2026-06
Dexcom USD 1.09B 182.1M 2026-03
Edwards Lifesciences USD 912.1M 19.3M 2025-12
Globus Medical USD 735.44M 8.23M 2026-03
Insulet USD 544.7M 27.8M 2026-03
Integra LifeSciences USD 264.41M 14.44M 2026-03
Intuitive Surgical USD 1.67B 77.6M 2026-06
J&J USD 22.54B 1.21B 2026-03
Medtronic USD 6.36B 30M 2025-12
Merit Medical Systems USD 227M 3.39M 2026-03
Pfizer USD 16.17B 332M 2026-03
Smith & Nephew USD 1.48B 85M 2025-12
Solventum Corp USD 1.35B 163M 2026-03
Stryker USD 3.57B 468M 2026-03
Tandem Diabetes Care USD 165.49M 39.55M 2025-12
Teleflex USD 365.53M 19.94M 2026-03
Terumo JPY 217.57B 2.28B 2026-03
Thermo Fisher Scientific USD 9.2B 304M 2026-03
Zimmer Biomet Holdings USD 1.73B 24.2M 2026-03